Literature DB >> 31317460

Apneic Oxygenation During Prolonged Laryngoscopy in Obese Patients: a Randomized, Double-Blinded, Controlled Trial of Nasal Cannula Oxygen Administration.

Tiffany S Moon1, Katie Tai2, Agnes Kim2, Michael X Gonzales2, Rachael Lu2, Taylor Pak2, Katelynn Smith2, Joy L Chen2, Abu T Minhajuddin2, Nwamaka Nnamani2, Pamela E Fox2, Babatunde Ogunnaike2.   

Abstract

BACKGROUND: Obese patients have a propensity to desaturate during induction of general anesthesia secondary to their reduced functional residual capacity and increased oxygen consumption. Apneic oxygenation can provide supplemental oxygen to the alveoli, even in the absence of ventilation, during attempts to secure the airway. In this study, we hypothesized that oxygen administration through a nasopharyngeal airway and standard nasal cannula during a simulated prolonged laryngoscopy would significantly prolong the safe apneic duration in obese patients.
METHODS: One hundred thirty-five obese patients undergoing non-emergent surgery requiring general anesthesia were randomized to either the control group or to receive apneic oxygenation with air versus oxygen. All patients underwent a standard intravenous induction. For patients randomized to receive apneic oxygenation, a nasopharyngeal airway and standard nasal cannula were inserted. A simulated prolonged laryngoscopy was performed to determine the duration of the safe apneic period, defined as the beginning of laryngoscopy until the peripheral oxygen saturation (SpO2) reached 95%.
RESULTS: The oxygen group had a median safe apneic duration that was 103 s longer than the control group. The lowest mean SpO2 value during the induction period was 3.8% higher in the oxygen group compared to the control group. Following intubation, patients in the oxygen group had a mean end tidal carbon dioxide (ETCO2) level that was 3.0 mmHg higher than patients in the control group.
CONCLUSIONS: In obese patients, oxygen insufflation at 15 L/min through a nasopharyngeal airway and standard nasal cannula can significantly increase the safe apneic duration during induction of anesthesia.

Entities:  

Keywords:  Airway management; Apneic oxygenation; Difficult intubation; Laryngoscopy; Obesity

Mesh:

Substances:

Year:  2019        PMID: 31317460     DOI: 10.1007/s11695-019-04077-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  23 in total

1.  Respiratory effects of obesity.

Authors:  R M CHERNIACK
Journal:  Can Med Assoc J       Date:  1958-04-15       Impact factor: 8.262

2.  Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation.

Authors:  A S Baraka; S K Taha; S M Siddik-Sayyid; G E Kanazi; M F El-Khatib; C M Dagher; J-M A Chehade; F W Abdallah; R E Hajj
Journal:  Anaesthesia       Date:  2007-08       Impact factor: 6.955

3.  Trends in Obesity Among Adults in the United States, 2005 to 2014.

Authors:  Katherine M Flegal; Deanna Kruszon-Moran; Margaret D Carroll; Cheryl D Fryar; Cynthia L Ogden
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

Review 4.  The effectiveness of apneic oxygenation during tracheal intubation in various clinical settings: a narrative review.

Authors:  David T Wong; Amanda J Yee; Siaw May Leong; Frances Chung
Journal:  Can J Anaesth       Date:  2017-01-03       Impact factor: 5.063

5.  Pharyngeal insufflation of oxygen prevents arterial desaturation during apnea.

Authors:  L E Teller; C M Alexander; M J Frumin; J B Gross
Journal:  Anesthesiology       Date:  1988-12       Impact factor: 7.892

6.  Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration.

Authors:  Satya Krishna Ramachandran; Amy Cosnowski; Amy Shanks; Christopher R Turner
Journal:  J Clin Anesth       Date:  2010-05       Impact factor: 9.452

7.  Difficult tracheal intubation in obstetrics.

Authors:  R S Cormack; J Lehane
Journal:  Anaesthesia       Date:  1984-11       Impact factor: 6.955

8.  A randomized trial on subject tolerance and the adverse effects associated with higher- versus lower-flow oxygen through a standard nasal cannula.

Authors:  Andrew Brainard; Danny Chuang; Irene Zeng; G Luke Larkin
Journal:  Ann Emerg Med       Date:  2014-11-20       Impact factor: 5.721

9.  Increases in morbid obesity in the USA: 2000-2005.

Authors:  R Sturm
Journal:  Public Health       Date:  2007-03-30       Impact factor: 2.427

10.  Improvement of gas exchange by apneic oxygenation with nasal prong during fiberoptic intubation in fully relaxed patients.

Authors:  S C Lee
Journal:  J Korean Med Sci       Date:  1998-12       Impact factor: 2.153

View more
  6 in total

1.  [Is pre-oxygenation with high-flow nasal oxygen safe? randomized control trial of 56 cases of elderly patients during induction of general anesthesia with endotracheal intubation].

Authors:  Q Cai; W Ma; C Wu; H Liu; S Wang; G Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-07-20

Review 2.  Airway management in patients with obesity.

Authors:  Bhavana Thota; Kathryn M Jan; Matthew W Oh; Tiffany S Moon
Journal:  Saudi J Anaesth       Date:  2022-01-04

Review 3.  Pre-oxygenation and apneic oxygenation in patients living with obesity - A review of novel techniques.

Authors:  Tomasz Gaszynski; Andrew McKechnie
Journal:  Saudi J Anaesth       Date:  2022-06-20

Review 4.  Airway management in patients suffering from morbid obesity.

Authors:  Wan Jane Liew; Asadi Negar; Prit Anand Singh
Journal:  Saudi J Anaesth       Date:  2022-06-20

Review 5.  Patients with sleep-disordered breathing for bariatric surgery.

Authors:  Matthew W Oh; Joy L Chen; Tiffany S Moon
Journal:  Saudi J Anaesth       Date:  2022-06-20

6.  Time to adapt in the pandemic era: a prospective randomized non -inferiority study comparing time to intubate with and without the barrier box.

Authors:  Praneeth Madabhushi; Sudhakar Kinthala; Abistanand Ankam; Nitin Chopra; Burdett R Porter
Journal:  BMC Anesthesiol       Date:  2020-09-14       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.